Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Pharmacological Research|October 13, 2006
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol [EudraCT no.: 2006-000032-27]Davide Pareyson, Angelo Schenone, Gian Maria Fabrizi, et al.International Journal of Molecular Sciences|February 10, 2024
Charcot-Marie-Tooth Disease with Myelin Protein Zero Mutation Presenting as Painful, Predominant Small-Fiber NeuropathyFranco Gemignani, Antonio Percesepe, Francesca Gualandi, et al.Neuromuscular Disorders : NMD|March 31, 2019
Are novel outcome measures for Charcot-Marie-Tooth disease sensitive to change? The 6-minute walk test and StepWatch™ Activity Monitor in a 12-month longitudinal studyCostanza Pazzaglia, Luca Padua, Davide Pareyson, et al.The Lancet. Neurology|March 12, 2011
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trialDavide Pareyson, Mary M Reilly, Angelo Schenone, et al.Neuromuscular Disorders : NMD|August 3, 2014
Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patientsManoj Mannil, Alessandra Solari, Andreas Leha, et al.Pageof 2